Skip to main content
. 2015 Mar 16;7(3):886–899. doi: 10.3390/toxins7030886

Figure 4.

Figure 4

Further separation of fraction F7 from the molecular sieve chromatography and mass spectrometric analysis of the purified peptide. (A) RP-HPLC of the fraction F7; (B) MALDI-TOF mass spectrometric analysis of the purified peptide.